Heartseed, Inc.
public_traded
Heartseed, Inc. is publicly traded on JPX under ticker 219A.T.
Heartseed, Inc. engages in the provision of cardiac regenerative medicine. The company was founded by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa and Yutaro Kasai on November 30, 2015 and is headquartered in Tokyo, Japan.